We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.71B
AUM Growth
-$44.3M
Cap. Flow
-$66.1M
Cap. Flow %
-2.44%
Top 10 Hldgs %
17.98%
Holding
299
New
64
Increased
62
Reduced
142
Closed
18

Top Sells

Rank Stock Value
1
CHGG icon
Chegg
CHGG
+$22.7M
2
TREX icon
Trex
TREX
+$17.5M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$15.4M
4
TTEK icon
Tetra Tech
TTEK
+$15.3M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$15.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 17.94%
3 Consumer Discretionary 17%
4 Industrials 15.63%
5 Financials 14.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUBI icon
51
Customers Bancorp
CUBI
$2.65B
$21.8M 0.8%
333,636
+325,616
+4,060% +$17.9M
DKS icon
52
Dick's Sporting Goods
DKS
$19.5B
$21.2M 0.78%
184,426
-109,602
-37% -$13.1M
ITGR icon
53
Integer Holdings
ITGR
$3.24B
$21.1M 0.78%
246,129
-8,059
-3% -$704K
TREX icon
54
Trex
TREX
$4.69B
$21.1M 0.78%
155,976
-145,446
-48% -$17.5M
COHU icon
55
Cohu
COHU
$2.41B
$20.4M 0.75%
536,235
-262,794
-33% -$9.01M
FORM icon
56
FormFactor
FORM
$8.23B
$20.4M 0.75%
445,961
+97,907
+28% +$4.01M
GOSS icon
57
Gossamer Bio
GOSS
$83.2M
$20M 0.74%
1,770,919
+254,916
+17% +$3.03M
MODN
58
DELISTED
MODEL N, INC.
MODN
$20M 0.74%
665,160
+420
+0.1% +$13.1K
RARE icon
59
Ultragenyx Pharmaceutical
RARE
$2.88B
$19.8M 0.73%
235,745
+39,621
+20% +$3.22M
FA icon
60
First Advantage
FA
$3.83B
$19.3M 0.71%
1,015,586
+51,617
+5% +$994K
AIMC
61
DELISTED
Altra Industrial Motion Corp
AIMC
$18.8M 0.69%
364,305
-7,550
-2% -$415K
HRI icon
62
Herc Holdings
HRI
$4.99B
$18.3M 0.67%
+116,724
New +$20.6M
BPMC
63
DELISTED
Blueprint Medicines
BPMC
$18.2M 0.67%
169,659
-63,849
-27% -$6.68M
WGO icon
64
Winnebago Industries
WGO
$868M
$17.5M 0.64%
233,251
-28,159
-11% -$2.03M
FARO
65
DELISTED
Faro Technologies
FARO
$17.4M 0.64%
247,975
-4,075
-2% -$293K
CCOI icon
66
Cogent Communications
CCOI
$549M
$17.2M 0.64%
235,638
-16,902
-7% -$1.27M
ACAD icon
67
Acadia Pharmaceuticals
ACAD
$4.38B
$16.7M 0.62%
+717,318
New +$14.4M
PING
68
DELISTED
Ping Identity Holding Corp.
PING
$15.9M 0.59%
693,687
+176,312
+34% +$4.49M
DOOR
69
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$15.6M 0.58%
132,298
-37,291
-22% -$4.27M
LIND icon
70
Lindblad Expeditions
LIND
$1.82B
$15.2M 0.56%
973,885
+147,940
+18% +$2.34M
HAYW icon
71
Hayward Holdings
HAYW
$3.12B
$15.1M 0.56%
577,528
-8,224
-1% -$199K
WOOF icon
72
Petco
WOOF
$760M
$15M 0.55%
759,720
-11,836
-2% -$259K
QTWO icon
73
Q2 Holdings
QTWO
$3.43B
$15M 0.55%
188,271
-4,055
-2% -$327K
SNCY
74
DELISTED
Sun Country Airlines
SNCY
$14.4M 0.53%
526,963
+101,563
+24% +$3.03M
SKYT icon
75
SkyWater Technology
SKYT
$1.54B
$14.1M 0.52%
867,511
+267,214
+45% +$5.98M

Similar funds

Emerald Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, Emerald Advisers held 299 positions worth $2.71B, down 1.6% from $2.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q4 2021 filing shows 64 new, 62 increased, 142 reduced and 18 closed positions. Its largest new stake was Herc Holdings: 116,724 shares worth $18.3M. The largest sale was Chegg, an estimated $22.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2021 buy was Herc Holdings: 116,724 shares worth $18.3M.
  • Emerald Advisers added most to Customers Bancorp in Q4 2021, an estimated $17.9M increase.
  • Emerald Advisers's biggest Q4 2021 reduction was Chegg, cutting an estimated $22.7M.
  • Emerald Advisers fully exited Oric Pharmaceuticals in Q4 2021, selling an estimated $15.2M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.71B portfolio in Q4 2021.
  • Emerald Advisers opened 64 new positions and closed 18 in Q4 2021.
  • Emerald Advisers's portfolio value fell 1.6% quarter-over-quarter to $2.71B.

Based on Emerald Advisers's 13F filing for Q4 2021, filed 2 Feb 2022.